JATT II Acquisition Corp. (JATT)
NASDAQ: JATT · Real-Time Price · USD
10.32
-0.62 (-5.67%)
Apr 28, 2026, 12:53 PM EDT - Market open
| Market Cap | 80.50M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 7.80M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,158 |
| Open | 10.50 |
| Previous Close | 10.94 |
| Day's Range | 10.50 - 10.92 |
| 52-Week Range | 9.99 - 11.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About JATT
JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses. The company was incorporated in 2026 and is based in Westfield, New Jersey. [Read more]
Industry Shell Companies
Sector Financials
IPO Date Apr 17, 2026
Country United States
Stock Exchange NASDAQ
Ticker Symbol JATT
News
JATT II's Biotech SPAC Debut: Sponsor's Varied History Faces a Doubtful Market
JATT II Acquisition: A New SPAC Targeting Biotech JATT II Acquisition, a newly formed blank check company focused on the biotech and life sciences sectors, | Bitget crypto news!
25 days ago - Bitget News
JATT II Acquisition IPO Registration Document (S-1)
JATT II Acquisition has filed to go public with an IPO on the NASDAQ
25 days ago - SEC
SPAC JATT II Acquisition files for a $60 million IPO, targeting biotech and life sciences
JATT II Acquisition, a blank check company targeting biotechs and life sciences businesses, filed on Friday with the SEC to raise up to $60 million in an initial public offering.
6 weeks ago - Renaissance Capital